question,Answer / DB,Answer / EH,Answer / MC,Interpersonal Agreement,Majority Vote,Correct Answer,Answer / DoX,Answer / ChatGPT 3.5,Answer / ChatGPT 4
"Where appropriate, is training provided to users?",No,N/A,Yes,N,N,"Y, the given manual can be seen as a form of training","Yes, training is provided to users. Detailed instructions on how to use the system are available in a separate User Guide. The guide can be found in the 'Help' section of the application or can be downloaded from the official website. It caters to the needs of multiple user groups, explaining the functionalities tailored to each (paragraph 6).",Y,Y
"Where applicable, are installation instructions provided?",No,"Y, in separate doc",No,N,N,"Y, in separate doc","Yes, installation instructions are provided. The guide provides step-by-step installation procedures for On-Premises, Cloud-Based, and API Integration deployment options (paragraph 1). Additionally, to install the AI-based Medical Expenditure System, one can refer to the ""Installation Guide"" which can be accessed through the official website or within the software package (paragraph 2).",Y,Y
"Is there provision for adequate information pursuant to Article 13, especially regarding risks?",Yes,Y,Yes,Y,Y,Y,"Yes, there is provision for adequate information pursuant to Article 13, especially regarding risks. The AI system for medical expenditure prediction provides stakeholders with comprehensive information about the system's operation and associated risks, ensuring transparency throughout the process (paragraph 3). The system operates within a robust risk management framework that is continuously updated and thoroughly documented to ensure transparency and compliance (paragraph 8). Risks such as inaccurate predictions, privacy concerns, and miscommunication of medical expenditure estimates are evaluated and quantified (paragraph 1). Furthermore, the system implements mitigation and control measures for risks that cannot be completely eliminated, including regular bias audits, data quality checks, and performance evaluations (paragraph 14).",Y,N
Is there information on the degrees of accuracy for specific target groups?,Yes,N,No,N,N,"N, the technology is there to keep track of potential unfairness and biases but the degrees of accuracy are not mentioned.","Yes, there is information on the degrees of accuracy for specific target groups. The AI system's performance is monitored across different patient groups to detect and address any potential bias or discrimination (paragraph 0). The system uses fairness metrics like disparate impact and average odds difference to monitor its fairness (paragraph 3). The Fairness Indicators framework is used to detect and quantify bias in the AI system's decisions, allowing for the computation of fairness metrics and comparison of the distribution of expenditures for different patient groups (paragraph 7).",Y,N
"Is there information on how the AI system interacts with hardware or software that is not part of the AI system itself, where applicable?",Yes,"Y, but not all dependencies listed",Yes,Y,"Y, partially",Y,"No, I cannot answer.",Y,Y
"Is there information about the computational resources used in different phases like development, training, testing, and validation?",Yes,Y,Yes,Y,Y,Y,"Yes, there is information about the computational resources used in different phases like development, training, testing, and validation. During the development phase, it is advisable to use a development environment with at least 16 GB RAM and an Intel Core i7 processor or equivalent (paragraph 1 and 3). For the training phase, the system's models are trained on high-performance computing clusters with GPUs, with a minimum of 32 GB RAM and Nvidia Tesla V100 GPUs being essential for efficient model training (paragraph 0). The testing phase is carried out on machines with similar specifications to the training environment but can be performed on less powerful hardware, like Nvidia Tesla P100 GPUs and 16 GB RAM (paragraph 0). Lastly, the validation phase is generally conducted on machines with at least 16 GB RAM and an Intel Core i7 processor or equivalent to ensure the model's robustness and generalizability (paragraph 0).",Y,N
"Is there evidence that a risk management system has been established, implemented, documented, and maintained for high-risk AI systems?",Yes,Y,Yes,Y,Y,Y,"Yes, there is evidence that a risk management system has been established, implemented, documented, and maintained for high-risk AI systems. The risk management process begins with the identification and analysis of known and foreseeable risks associated with the operation of the AI system (paragraph 5). The system design is continuously reviewed and updated to eliminate or minimize risks (paragraph 1). The high-risk AI system undergoes rigorous testing to determine the most appropriate risk management measures (paragraph 2). The risk management framework is continuously updated and thoroughly documented to ensure transparency and compliance (paragraph 7). The AI system also incorporates several layers of human oversight to fulfill regulatory requirements (paragraph 8). The AI system is designed with built-in human oversight mechanisms to ensure the accuracy and appropriateness of the predictions (paragraph 15). The system's validation involves a rigorous testing process, including stress tests and edge cases (paragraph 19).",Y,N
Is there an assessment of human oversight measures as per Article 14?,Yes,Y,Yes,Y,Y,Y,"Yes, there is an assessment of human oversight measures as per Article 14. The AI system for medical expenditure prediction incorporates several layers of human oversight to fulfill these requirements. These include version control, audit trails, compliance audits, continuous monitoring, feedback loops, update protocols, decision reviews, explainability features, manual overrides, fairness assessment, and data protection. Independent third-party organizations regularly perform audits to ensure the system's compliance with ethical guidelines, data protection standards, and fairness considerations. These audits validate that human oversight is effectively implemented. The system also uses fairness metrics like disparate impact and average odds difference to monitor its fairness. Human reviewers assess these metrics to ensure the system meets ethical and regulatory standards (paragraph 3, 4, 5, 10).",Y,Y
Is there a provision for regular systematic updates?,Yes,Y,Yes,Y,Y,Y,"Yes, there is a provision for regular systematic updates. Based on the results of ongoing monitoring and routine performance evaluations, updates may be implemented to enhance the AI system's performance or functionality (paragraph 2). A standardized protocol is in place for updating the system based on monitoring results and feedback, ensuring that the system adapts to new data patterns and regulatory changes effectively (paragraph 6). Each update undergoes rigorous validation and testing before deployment to ensure that it improves the system's performance and does not introduce new risks or biases (paragraph 0). All updates are logged and documented to maintain a transparent record of the system's evolution and improvements (paragraph 0).",Y,N
"Is there a provision for individuals to intervene on the operation of the high-risk AI system or to interrupt the system, such as through a ""stop"" button or a similar procedure?",Yes,Y,No,N,Y,Y,"Yes, there is a provision for individuals to intervene on the operation of the high-risk AI system or to interrupt the system. The AI system for medical expenditure prediction incorporates several layers of human oversight, including the capability for human operators to manually override predictions (paragraph 0). The system also includes built-in safety mechanisms that allow for easy reversal of automated actions (paragraph 3). Furthermore, all users have the discretion to opt-out, override, or reverse decisions generated by the system (paragraph 11).",Y,Y
Is there a list of applied harmonized standards?,Yes,Y,Yes,Y,Y,Y,"Yes, there is a list of applied harmonized standards. The Medical Expenditure AI Model conforms to the following standards and specifications: ISO/IEC 27001: Information Security Management, ISO/IEC 27701: Privacy Information Management, ISO/IEC 38505-1: Governance of Data, IEEE P7003: Algorithmic Bias Considerations, and ISO/IEC TR 24028:2020: Artificial Intelligence (AI) -- Overview of trustworthiness in Artificial Intelligence (paragraph 1, 3, 8).",Y,N
Is there a judgment on the acceptability of any residual risks?,Yes,Y,Yes,Y,Y,Y,"Yes, there is a judgment on the acceptability of any residual risks. Residual risks associated with each identified hazard and the overall residual risk of the system are considered acceptable as long as the system is used for its intended purpose. The residual risks are communicated to users to ensure they have a clear understanding of the system's limitations and potential issues (paragraph 0). Furthermore, mitigation and control measures are implemented for risks that cannot be completely eliminated. These measures include regular bias audits, data quality checks, and performance evaluations of the AI system (paragraph 9).",Y,N
Is there a detailed description of the system to evaluate the AI system's performance in the post-market phase?,Yes,Y,,N,Y,Y,"Yes, there is a detailed description of the system to evaluate the AI system's performance in the post-market phase. The evaluation comprises several critical components, including ongoing monitoring, routine performance evaluations, bias detection and mitigation, and system updates (Paragraph 0). The AI system undergoes continuous monitoring to track its performance and identify any deviations in the system's behavior or the data it processes (Paragraph 2). Regular routine performance evaluations of the AI system are conducted, involving a comprehensive review of the system's performance metrics and a detailed analysis of the system's decisions and their impacts (Paragraph 5). The system also incorporates several layers of human oversight to ensure transparency, fairness, and compliance with regulatory and ethical guidelines (Paragraph 6). The AI system's performance metrics are compared against predefined thresholds and historical benchmarks to identify any anomalies or unexpected changes (Paragraph 7). Feedback from medical professionals, stakeholders, and end-users is also solicited to identify areas of improvement and address any potential biases or limitations in the system's predictions (Paragraph 8). Regular audits of the post-market evaluation procedures are conducted to ensure transparency and accountability (Paragraph 11). Advanced tools and techniques are utilized to detect and quantify bias in the AI system's decisions (Paragraph 12). Based on the results of ongoing monitoring and routine performance evaluations, updates may be implemented to the AI system to enhance its performance or functionality (Paragraph 16).",Y,N
"Is the system architecture, including software component interactions, explained?",Yes,Y,Yes,Y,Y,Y,"Yes, the system architecture, including software component interactions, is explained. The system follows a modular architecture, with distinct components for data processing, model training, fairness assessment, bias mitigation, and explainability (paragraph 0). The AI system for the medical expenditure prediction is designed with a focus on fairness, interpretability, and accuracy (paragraph 8). The system is developed on the IBM AIX360 platform and utilizes a range of dependencies, including 'joblib', 'scikit-learn', 'torch', 'tensorflow', 'keras', 'matplotlib', 'numpy', 'pandas', 'scipy', 'xgboost', and others (paragraph 9). The system can be deployed in various forms such as On-Premises, Cloud-Based, and API Integration (paragraph 10). The system design, including the machine learning models and explanatory algorithms, is continuously reviewed and updated to eliminate or minimize risks (paragraph 15).",Y,N
Is the hardware on which the AI system is intended to run described?,Yes,Y,No,N,Y,Y,"Yes, the hardware on which the AI system is intended to run is described. During the training phase, the system's models are trained on high-performance computing clusters with GPUs, with a minimum of 32 GB RAM and Nvidia Tesla V100 GPUs being essential for efficient model training. Testing is carried out on machines with similar specifications to the training environment but can be performed on less powerful hardware, like Nvidia Tesla P100 GPUs and 16 GB RAM. Validation is generally conducted on machines with at least 16 GB RAM and an Intel Core i7 processor or equivalent (paragraph 0). During the data pre-processing and source code development, it is advisable to use a development environment with at least 16 GB RAM and an Intel Core i7 processor or equivalent (paragraph 4). To deploy the AI-based Medical Expenditure System, the following system requirements should be met: Compatibility with Windows, Linux, and macOS, a minimum requirement of an Intel Core i5 processor, at least 8 GB RAM for optimal performance, a minimum of 100 GB of free disk space, a dedicated Nvidia graphics card, a stable internet connection for seamless API access, and Python 3.6 or later (paragraph 1).",Y,Y
Is the date and version of the system provided?,Yes,Y,Yes ,Y,Y,Y,"Yes, the date and version of the system are provided. The current version of the system is 1.4.0 (paragraph 0, 6). The system was last updated in June 2023 (paragraph 2, 6).",Y,Y
Is specific consideration given to whether the high-risk AI system is likely to be accessed by or impact children?,No,"Y, but not detailed",No,N,N,"Y, but not detailed","Yes, specific consideration is given to whether the high-risk AI system is likely to be accessed by or impact children. The development and updating of the risk management system takes into account the environment in which the system is intended to be used and its potential impact, including considerations related to patients of different age groups (paragraph 11).",Y,N
"Is due consideration given to the technical knowledge, experience, education, and training expected from the user and the environment where the system will be used?",Yes,Y,Yes,Y,Y,Y,"Yes, due consideration is given to the technical knowledge, experience, education, and training expected from the user and the environment where the system will be used. This is evident in the development and updating of the risk management system, where these factors are taken into account (paragraph 0 and 1). The environment in which the system is intended to be used and its potential impact, including considerations related to patients of different age groups, are also considered (paragraph 0).",Y,Y
Is a copy of the EU declaration of conformity included in the documentation?,Yes,Y (version doesn’t match what’s stated in body),Yes,Y,Y,Y,"Yes, a copy of the EU declaration of conformity is included in the documentation. It includes the AI system's name, type, and additional reference for identification and traceability, the name and address of the provider, a statement that the declaration is issued under the sole responsibility of the provider, a statement of conformity with the AI Act and other relevant Union legislation, references to relevant standards and specifications, the name and identification number of the notified body, a description of the conformity assessment procedure, and the certificate issued. It also includes the place and date of issue, the name and function of the person who signed it, and an indication for, and on behalf of whom, that person signed (paragraph 1).",Y,N
"If the AI system is for credit institutions regulated by Directive 2013/36/EU, does it adhere to the risk management procedures pursuant to Article 74 of that Directive?",N/A,N/A,,Y,N,N,"No, I cannot answer.",Y,N
"If no harmonized standards are applied, is there a description of the solutions adopted to meet the requirements?",N/A,N/A,Yes,N,N,Y,"Yes, when no harmonized standards are applied, the solutions adopted to meet the requirements include relying on industry best practices within the machine learning and AI domain. These practices include advanced data preprocessing techniques, the use of the XGBoost predictive model, prioritizing explainability and transparency through the use of explanatory models, and the integration of eXplainable Artificial Intelligence (XAI) algorithms. These measures ensure the accuracy, fairness, and transparency of the medical expenditure AI system (paragraph 1).",Y,N
"If applicable, are there photographs or illustrations available that show the external features, marking, and internal layout of products in which the AI system is a component?",No,N/A,No,Y,N,N,"No, I cannot answer.",Y,N
"For systems identified in point 1(a) of Annex III, does the human oversight measure ensure that no action or decision is taken based on the AI system's identification unless verified and confirmed by at least two natural persons?",N/A,N/A,No,Y,N,N,"No, I cannot answer.",N,Y
Does the technical documentation indicate that the high-risk AI system is designed and developed to be effectively overseen by natural persons?,Yes,Y,Yes,Y,Y,Y,"Yes, the technical documentation indicates that the high-risk AI system is designed and developed to be effectively overseen by natural persons. The AI system is designed with built-in human oversight mechanisms to ensure the accuracy and appropriateness of the predictions (Paragraph 0, 1, 4). These layers of human oversight aim to ensure that the AI system aligns with ethical and regulatory mandates (Paragraph 2). Insurance companies, government agencies, and employers who might use this system can also exercise discretion and validate the AI's predictions with additional assessments or human oversight (Paragraph 3). The system incorporates several layers of human oversight to fulfill the requirements of transparency, fairness, and regulatory and ethical guidelines (Paragraph 5). The system is designed with the capability for human operators to manually override predictions (Paragraph 5). The system also undergoes regular audits and assessments to maintain compliance with internal policies and external regulations (Paragraph 9, 12).",Y,Y
Does the risk management system include evaluation of risks based on data gathered from post-market monitoring?,Yes,Y,Yes,Y,Y,Y,"Yes, the risk management system includes evaluation of risks based on data gathered from post-market monitoring. The post-market monitoring system gathers and analyzes data to identify emerging risks, monitor model performance, and detect any unexpected system behavior (paragraph 0). The identification and evaluation of risks lead to the adoption of appropriate risk management measures (paragraph 1). The AI system's performance evaluation in the post-market phase includes ongoing monitoring, routine performance evaluations, bias detection and mitigation, and system updates (paragraph 2). Risks that arise from the intended use of the system and under conditions of reasonably foreseeable misuse are estimated and evaluated (paragraph 5). The AI system undergoes continuous monitoring in the post-market phase to track its performance and identify any deviations in the system's behavior or the data it processes (paragraph 6).",Y,N
"Does the documentation specify how human oversight aims to prevent or minimize risks to health, safety, or fundamental rights?",Yes,Y,Yes ,Y,Y,Y,"Yes, the documentation specifies how human oversight aims to prevent or minimize risks to health, safety, or fundamental rights. The AI system for medical expenditure prediction incorporates several layers of human oversight to ensure that the system is transparent, adaptable, and ethically responsible (paragraph 0). These measures include version control, audit trails, compliance audits, continuous monitoring, feedback loops, update protocols, explainability features, manual overrides, fairness assessment, and data protection (paragraph 6). The system is designed with the capability for human operators to manually override predictions, which is crucial in situations where the AI system's output may not fully capture the complexities of medical expenditure (paragraph 6). Independent third-party organizations regularly perform audits to ensure the system's compliance with ethical guidelines, data protection standards, and fairness considerations (paragraph 6). The system also has limitations and potential risks, which are addressed through comprehensive data processing, bias mitigation algorithms, and robust human oversight measures (paragraph 3).",Y,Y
Does the documentation show evidence of elimination or reduction of risks through adequate design and development?,Yes,Y,Yes,Y,Y,Y,"Yes, the documentation shows evidence of elimination or reduction of risks through adequate design and development. The system design, including the machine learning models and explanatory algorithms, is continuously reviewed and updated to eliminate or minimize risks (paragraph 3 and 4). The risk management process involves identifying and analyzing known and foreseeable risks associated with the operation of the AI system, including a comprehensive examination of the system's design, the features it utilizes, and the decision-making processes it employs (paragraph 8). Mitigation and control measures are implemented for risks that cannot be completely eliminated, including regular bias audits, data quality checks, and performance evaluations of the AI system (paragraph 11). The AI system incorporates a Reweighing algorithm that reduces bias in the training data, promoting fairness and non-discrimination (paragraph 18). Furthermore, explainable AI tools and models have been incorporated to balance performance and transparency (paragraph 19).",Y,Y
Does the documentation indicate that the risk management system is a continuous iterative process run throughout the entire lifecycle of the high-risk AI system?,Yes,Y,Yes,Y,Y,Y,"Yes, the documentation indicates that the risk management system is a continuous iterative process run throughout the entire lifecycle of the high-risk AI system. The first step in the risk management process is to identify and analyze known and foreseeable risks associated with the operation of the AI system (paragraph 0). Upon identification and evaluation of risks, appropriate risk management measures are adopted, and the system design is continuously reviewed and updated to eliminate or minimize risks (paragraph 1). The AI system undergoes continuous monitoring to track its performance and identify any deviations in the system's behavior or the data it processes in the post-market phase (paragraph 6). This ongoing process allows the identification of emerging risks, monitoring of model performance, and detection of any unexpected system behavior (paragraph 4, 11). After the deployment of the AI system, it is crucial to continuously monitor and evaluate its performance to ensure that it maintains its intended functionality, accuracy, and reliability (paragraph 9, 13).",Y,N
Does the documentation include a general description stating the intended purpose of the AI system?,Yes,Y,Yes,Y,Y,Y,"Yes, the documentation includes a general description stating the intended purpose of the AI system. The AI-based Medical Expenditure System is designed to predict annual healthcare expenditure for individuals by leveraging demographic data, socio-economic factors, and self-reported medical conditions. Its primary customers are healthcare ""payers"" like insurance companies, government agencies, employers, and individuals who are financially responsible for medical costs (paragraph 18).",Y,Y
Does the documentation detail the capabilities and limitations of the AI system?,Yes,Y,Yes,Y,Y,Y,"Yes, the documentation details the capabilities and limitations of the AI system. The AI system can process a wide range of data, but it is designed to avoid using sensitive personal attributes, such as race or gender, in its prediction process (paragraph 0). It also incorporates external datasets and information to enhance the accuracy of its predictions, subject to availability, relevance, and strict compliance with data privacy laws and regulations (paragraph 6). The system utilizes a primary predictive model known as XGBoost, which is a gradient boosting framework that combines multiple decision trees to create a powerful learner (paragraph 10).",Y,Y
Does the documentation describe the methods and steps performed for the development of the AI system?,Yes,N,Yes,N,Y,Y,"Yes, the documentation describes the methods and steps performed for the development of the AI system. The AI system is developed by a team of data scientists and AI experts (paragraph 0). The system is designed with built-in human oversight mechanisms to ensure the accuracy and appropriateness of the predictions (paragraph 1). The development process is tracked and audited using GitHub, with every change logged and timestamped for transparency and accountability (paragraph 4).",Y,Y
Does the documentation describe any pre-determined changes to the system and its performance?,Yes,N,Yes,N,Y,Y,"Yes, the documentation describes pre-determined changes to the system and its performance. Based on the results of ongoing monitoring and routine performance evaluations, updates may be implemented to enhance the system's performance or functionality. These updates could include adjusting the AI model's parameters, incorporating new features or data sources, or upgrading the AI algorithms (Paragraph 1). The system's performance is also regularly monitored and updated to detect and address emerging biases, ensuring compliance with regulations and adaptability to changing trends (Paragraph 6). A standardized protocol is in place for updating the system based on monitoring results and feedback, ensuring that the system adapts to new data patterns and regulatory changes effectively (Paragraph 7). The AI system's performance metrics are compared against predefined thresholds and historical benchmarks to identify any anomalies or unexpected changes (Paragraph 9). The AI-based Medical Expenditure System has undergone several updates to improve its performance, security, and user experience (Paragraph 10).",Y,N
Does the documentation describe any changes made to the system throughout its lifecycle?,Yes,Y,Yes,Y,Y,Y,"Yes, the documentation describes several changes made to the AI-based Medical Expenditure System throughout its lifecycle. The system has undergone several updates to improve its performance, security, and user experience. The major changes include the initial release with XGBoost algorithm for medical expenditure prediction, introduction of Linear Rule Regression (LinRR) and Boolean Rule Column Generation (BRCG) algorithms for enhanced explainability, improved data pre-processing techniques, added support for additional operating systems, implementation of advanced bias detection and mitigation algorithms, upgrade to aix360 v0.2.1, addition of LimeTabularExplainer for improved model explainability, introduction of multi-language support for the user interface, and enhanced post-market monitoring features (paragraph 0). Each update undergoes rigorous validation and testing before deployment and all updates are logged and documented to maintain a transparent record of the system's evolution and improvements (paragraph 3). The system is regularly updated based on the results of ongoing monitoring and routine performance evaluations (paragraph 6). The use of GitHub for version control enables comprehensive tracking of all changes to the codebase (paragraph 8). The development process, data sources, model architecture, and any updates or modifications made to the system over time are documented to ensure transparency and accountability (paragraph 9).",Y,N
Does the documentation describe all forms in which the AI system is placed on the market or put into service?,Yes,Y,No,N,Y,Y,"Yes, the documentation describes all forms in which the AI system is placed on the market or put into service. The system can be deployed in various forms: On-Premises, for organizations wishing to host the system on their servers; Cloud-Based, available as a SaaS (Software as a Service) offering for easier access and lower upfront costs; and API Integration, for seamless integration into existing systems (paragraph 15).",Y,Y
Does the description of the system to evaluate the AI system's performance include a post-market monitoring plan as referred to in Article 61(3)?,Yes,Y,Yes,Y,Y,Y,"Yes, the description of the system to evaluate the AI system's performance includes a post-market monitoring plan as referred to in Article 61(3). The post-market monitoring system is implemented to gather and analyze data, identify emerging risks, monitor model performance, and detect any unexpected system behavior (paragraph 1). The system's performance evaluation in the post-market phase includes ongoing monitoring, routine performance evaluations, bias detection and mitigation, and system updates (paragraph 0, 2). The monitoring process is automated, utilizing real-time alerts to notify the team of any significant changes in performance metrics that could indicate issues with the system's functionality or performance (paragraph 3). Regular audits of the post-market evaluation procedures are conducted to ensure transparency and accountability (paragraph 11).",Y,N
Do the risk management measures reflect the generally acknowledged state of the art?,Yes,Y,Yes,Y,Y,Y,"Yes, the risk management measures reflect the generally acknowledged state of the art. The risk management measures include the application of all system requirements and state-of-the-art practices in the field of AI technology (paragraph 0 and 1). The system design, including the machine learning models and explanatory algorithms, is continuously reviewed and updated to eliminate or minimize risks (paragraph 1). Mitigation and control measures are implemented for risks that cannot be completely eliminated, including regular bias audits, data quality checks, and performance evaluations of the AI system (paragraph 2). The high-risk AI system undergoes rigorous testing to determine the most appropriate risk management measures (paragraph 3 and 5). The development and updating of the risk management system consider the technical knowledge, experience, education, and training expected from users (paragraph 4). The system also complies with industry-standard security protocols and follows best practices to safeguard against potential threats (paragraph 11). The risk management procedures form part of the institution's established risk management framework, in accordance with applicable regulations (paragraph 15).",Y,N
Do the risk management measures consider the effects and possible interactions resulting from combined application requirements?,No,"N, but I don’t totally understand what this means",Yes,N,N,"Y, but not straightforward to understand","Yes, the risk management measures consider the effects and possible interactions resulting from combined application requirements. The risk management process involves a comprehensive examination of the system's design, the features it utilizes, and the decision-making processes it employs, with special attention paid to potential misuse scenarios and the risks associated with them (paragraph 5). The system's performance is evaluated against defined metrics and probabilistic thresholds that are relevant to its intended purpose (paragraph 4). Furthermore, the risk management measures encompass the application of all system requirements and state-of-the-art practices in the field of AI technology (paragraph 1).",Y,N
Do the measures enable individuals to correctly interpret the high-risk AI system’s output?,Yes,Y,Yes,Y,Y,Y,"Yes, the measures enable individuals to correctly interpret the high-risk AI system’s output. The AI system incorporates built-in human oversight to ensure that the outputs are correct and the models are designed to be transparent, so their workings can be easily understood (paragraph 0). The system also incorporates several layers of human oversight to fulfill transparency, fairness, and regulatory requirements (paragraph 3). The use of LimeTabularExplainer and other explainability models provides an understandable reasoning behind each medical expenditure prediction, enabling human reviewers to assess the logic behind the predictions (paragraph 3). The system is designed with the capability for human operators to manually override predictions, providing a safeguard in situations where the AI system's output may not fully capture the complexities of medical expenditure (paragraph 3).",Y,Y
"Do the human oversight measures help individuals detect and address signs of anomalies, dysfunctions, and unexpected performance as soon as possible?",Yes,Y,No,N,Y,Y,"Yes, the human oversight measures help individuals detect and address signs of anomalies, dysfunctions, and unexpected performance as soon as possible. The AI system for medical expenditure prediction incorporates several layers of human oversight to fulfill these requirements. Real-time monitoring tools track the system's performance and fairness metrics, and any deviations trigger alerts for immediate human review (paragraph 3). The system's performance metrics are compared against predefined thresholds and historical benchmarks to identify any anomalies or unexpected changes, and an alert is triggered for further investigation if necessary (paragraph 5). The monitoring process is automated, utilizing real-time alerts to notify the team of any significant changes in these metrics that could indicate issues with the system's functionality or performance (paragraph 10). Furthermore, the system maintains an audit trail for model predictions, allowing for a review of decisions and actions, which is crucial for assessing the system's behavior and for future audits (paragraph 3).",Y,Y
Do testing procedures ensure consistent performance and compliance?,Yes,Y,Yes,Y,Y,Y,"Yes, testing procedures are designed to ensure consistent performance and compliance with the requirements outlined in the relevant sections (Paragraph 0, 1). The AI system undergoes rigorous testing to determine the most appropriate risk management measures and its performance is evaluated against defined metrics and probabilistic thresholds that are relevant to its intended purpose (Paragraph 0). The system is tested under different scenarios, including stress tests and edge cases, to ensure its robustness (Paragraph 2, 18). Testing is conducted throughout the development process, prior to deployment, and continues after deployment to ensure ongoing compliance and performance (Paragraph 3). Each update undergoes rigorous validation and testing before deployment to ensure that it improves the system's performance and does not introduce new risks or biases (Paragraph 4). Regular compliance checks are conducted and comprehensive documentation of evaluation procedures and their outcomes are maintained (Paragraph 5, 6). The AI model was subjected to rigorous testing to ensure its performance, reliability, and compliance with the specified requirements (Paragraph 7). The system is regularly monitored and updated to detect and address emerging biases, ensuring compliance with regulations and adaptation to changing trends (Paragraph 10). The system also undergoes regular audits and assessments to maintain compliance with internal policies and external regulations (Paragraph 16).",Y,N
"Can individuals decide not to use the high-risk AI system, or otherwise disregard, override, or reverse the output of the AI system?",Yes,Y,Yes,Y,Y,Y,"Yes, individuals can decide not to use the high-risk AI system, or otherwise disregard, override, or reverse the output of the AI system. Insurance companies, government agencies, and employers who might use this system for actuarial or administrative purposes can exercise discretion and have the full ability to opt-out of using the system if it does not meet their specific needs (paragraph 0). The AI-based Medical Expenditure System provides valuable predictions and insights, but these outputs are advisory in nature. Therefore, all users--healthcare data scientists, care managers, and medical staff--have the discretion to opt-out, override, or reverse decisions generated by the system (paragraph 1). Individual consumers who are financially responsible for their medical costs also have the option to disregard the system's predictions (paragraph 5). The system is designed with the capability for human operators to manually override predictions (paragraph 3).",Y,Y
"Are validation and testing procedures clearly defined, along with used metrics and test logs?",Yes,"Y. Partially, test logs not included",Yes,Y,"Y, partially","Y, partially","Yes, the validation and testing procedures are clearly defined, along with used metrics and test logs. The AI system's validation involves a rigorous testing process, evaluating the model's predictive power and robustness using well-defined metrics such as accuracy, R-squared, and fairness metrics (paragraph 0). The system is tested under different scenarios, including stress tests and edge cases (paragraph 0). The system's performance is evaluated against defined metrics and probabilistic thresholds that are relevant to its intended purpose (paragraph 2). Testing procedures are designed to ensure consistent performance and compliance with the requirements outlined (paragraph 2). Each update undergoes rigorous validation and testing before deployment to ensure that it improves the system's performance and does not introduce new risks or biases. All updates are logged and documented to maintain a transparent record of the system's evolution and improvements (paragraph 4). The performance of the models is assessed using various metrics, including R-squared (R2) scores and accuracy (paragraph 12). The system maintains an audit trail for model predictions, allowing for a review of decisions and actions (paragraph 14). The AI system's performance metrics are compared against predefined thresholds and historical benchmarks to identify any anomalies or unexpected changes (paragraph 16). The medical expenditure system utilizes a dataset divided into training, validation, and testing sets. The training set is used to train the models, the validation set helps in parameter tuning and preventing overfitting, and the testing set evaluates the model's performance on unseen data, simulating real-world scenarios (paragraph 18).",Y,N
"Are trade-offs in the technical solutions, such as accuracy vs. speed or privacy vs. functionality, clearly documented?",Yes,Y,No,N,Y,Y,"Yes, trade-offs in the technical solutions, such as accuracy vs. speed or privacy vs. functionality, are clearly documented. The system design required careful consideration of various trade-offs, such as the use of complex models that allow capturing intricate relationships in medical expenditure predictions, but may reduce explainability. To mitigate this challenge, explainable AI tools and models have been incorporated to balance performance and transparency (paragraph 0). In terms of data privacy, accuracy of medical expenditure predictions is prioritized while ensuring the protection of individual privacy. All data is anonymized, and strict data governance protocols are implemented (paragraph 1).",Y,N
Are these measures designed to enable individuals to understand the capacities and limitations of the AI system?,Yes,Y,Yes,Y,Y,Y,"Yes, these measures are designed to enable individuals to understand the capacities and limitations of the AI system. The AI system incorporates explainability as a key feature, with models designed to be transparent so their workings can be easily understood (paragraph 0). The system employs Protodash and CEM, XAI algorithms that provide explanations of medical expenditure predictions to healthcare professionals and patients (paragraph 1). The system also maintains an audit trail for model predictions, allowing for a review of decisions and actions (paragraph 2). The use of LimeTabularExplainer and other explainability models provides an understandable reasoning behind each medical expenditure prediction (paragraph 2). The system also integrates eXplainable Artificial Intelligence (XAI) algorithms, including Protodash and CEM, to facilitate the explanation of medical expenditure decisions (paragraph 5). The LimeTabularExplainer method is employed to generate explanations for the model predictions, providing insights into the label predictions made by the model and illustrating the importance of features and their contributions to the predictions (paragraph 8).",Y,Y
Are there sections detailing the use of any pre-trained systems or third-party tools?,Yes,N,No,N,N,Y,"Yes, there are sections detailing the use of pre-trained systems and third-party tools. The system is developed on the IBM AIX360 platform and utilizes the released version aix360 v0.2.1. It relies on a range of dependencies, including 'joblib', 'scikit-learn', 'torch', 'tensorflow', 'keras', 'matplotlib', 'numpy', 'pandas', 'scipy', 'xgboost', and others (paragraph 7). The AI system also employs Protodash and CEM, XAI algorithms that provide explanations of medical expenditure predictions to healthcare professionals and patients (paragraph 10). The system has undergone several updates, including the introduction of Linear Rule Regression (LinRR) and Boolean Rule Column Generation (BRCG) algorithms for enhanced explainability (paragraph 11). Advanced tools and techniques, such as the Fairness Indicators framework, are used to detect and quantify bias in the AI system's decisions (paragraph 12).",Y,Y
Are there instructions for users on how to use the AI system?,No,"Y, in separate doc",No,N,N,"Y, in separate doc","Yes, there are instructions for users on how to use the AI system. Detailed instructions on how to use the system are available in a separate User Guide. The guide can be found in the 'Help' section of the application or can be downloaded from the official website. It caters to the needs of multiple user groups, explaining the functionalities tailored to each (paragraph 0).",Y,Y
Are there any requirements related to version updates?,Yes,Y,Yes,Y,Y,Y,"Yes, there are requirements related to version updates. Each update undergoes rigorous validation and testing before deployment to ensure that it improves the system's performance and does not introduce new risks or biases (paragraph 0). Updates could entail adjusting the AI model's parameters, incorporating new features or data sources, or upgrading the AI algorithms (paragraph 2). All updates are logged and documented to maintain a transparent record of the system's evolution and improvements (paragraph 4). In case of critical issues or system failures, rollback procedures are in place to revert the system to its last stable version (paragraph 5). A standardized protocol is in place for updating the system based on monitoring results and feedback (paragraph 13). The system also prioritizes the security of third-party tools and keeps them up to date to maintain high standards and comply with relevant regulations (paragraph 3).",Y,N
Are the versions of relevant software or firmware listed?,Yes,N,Yes,N,Y,Y,"Yes, the versions of relevant software or firmware are listed. The system has undergone several updates, with versions 1.0.0, 1.1.0, 1.2.0, 1.3.0, and 1.4.0 mentioned (paragraph 5). The current version of the system is 1.4.0 (paragraph 2, 6). The system is developed on the IBM AIX360 platform and utilizes the released version aix360 v0.2.1 (paragraph 3, 7).",Y,Y
Are the persons or teams responsible for developing the AI system clearly identified?,No,N,Yes,N,N,"Y, but there is a general description of the team, but no detail information, no individual contact person.","Yes, the persons or teams responsible for developing the AI system are clearly identified. The AI system is developed by a dedicated team of data scientists and AI experts (paragraph 0 and 1).",Y,N
"Are the measures for human oversight identified and built into the high-risk AI system by the provider, or are they identified as appropriate to be implemented by the user?","Yes, built in",Y,"Yes, user",Y,Y,Y,"Yes, the measures for human oversight are identified and built into the high-risk AI system by the provider. The AI system for medical expenditure prediction incorporates several layers of human oversight to fulfill the requirements of transparency, fairness, and regulatory and ethical guidelines. These measures include version control, audit trails, compliance audits, continuous monitoring, feedback loops, update protocols, explainability features, manual overrides, fairness assessment, and data protection (Paragraph 0). The system is designed with built-in human oversight mechanisms to ensure the accuracy and appropriateness of the predictions (Paragraph 4). The system also allows for stakeholders to validate the AI's predictions with additional assessments or human oversight (Paragraph 5).",Y,Y
"Are the design specifications, including the general logic and algorithms, clearly outlined?",Yes,Y,Yes,Y,Y,Y,"Yes, the design specifications, including the general logic and algorithms, are clearly outlined. The AI system for medical expenditure prediction is designed with a focus on fairness, interpretability, and accuracy. It utilizes the Linear Rule Regression (LinRR) and Boolean Rule Column Generation (BRCG) algorithms (paragraph 2). The system follows a modular architecture, with distinct components for data processing, model training, fairness assessment, bias mitigation, and explainability (paragraph 8). The primary predictive model utilized in the system is XGBoost, and it also integrates eXplainable Artificial Intelligence (XAI) algorithms, including Protodash and CEM (paragraph 10). The system is developed on the IBM AIX360 platform and utilizes the released version aix360 v0.2.1 (paragraph 12). The system design, including the machine learning models and explanatory algorithms, is continuously reviewed and updated to eliminate or minimize risks (paragraph 1).",Y,Y
"Are the data requirements including datasheets, training methodologies, and data sets described?",Yes,Y. Partially,Yes,Y,"Y, partially","Y, partially","Yes, the data requirements including datasheets, training methodologies, and data sets are described. The medical expenditure system uses a dataset divided into training, validation, and testing sets (paragraph 1). The dataset contains anonymized patient information relevant to medical expenditures and complies with data privacy regulations (paragraph 3). Prior to training the machine learning models, all data undergoes thorough cleansing, normalization, and processing (paragraph 3). The system also employs advanced data preprocessing techniques such as data cleaning, feature selection based on domain knowledge, data normalization, and bias reduction methodologies (paragraph 4). The primary predictive model utilized in the system is XGBoost (paragraph 4). The system's models are trained on high-performance computing clusters with GPUs (paragraph 2). Testing is carried out on machines with similar specifications to the training environment but can be performed on less powerful hardware (paragraph 2). Validation is generally conducted on machines with at least 16 GB RAM and an Intel Core i7 processor or equivalent (paragraph 2).",Y,Y
Are testing procedures suitable for the intended purpose?,Yes,Y,Yes,Y,Y,Y,"Yes, the testing procedures are suitable for the intended purpose. The high-risk AI system undergoes rigorous testing to determine the most appropriate risk management measures. The system's performance is evaluated against defined metrics and probabilistic thresholds that are relevant to its intended purpose. Testing procedures are designed to ensure consistent performance and compliance with the requirements outlined in the documentation. These procedures are suitable to achieve the system's intended purpose without going beyond what is necessary (paragraph 0). The system is also tested under different scenarios, including stress tests and edge cases, to ensure its robustness (paragraph 3). Testing is conducted throughout the development process, prior to deployment, and continues after deployment to ensure ongoing compliance and performance (paragraph 5). Each update undergoes rigorous validation and testing before deployment to ensure that it improves the system's performance and does not introduce new risks or biases (paragraph 16).",Y,N
"Are testing procedures performed at appropriate times, including before market placement?",Yes,Y,Yes,Y,Y,Y,"Yes, testing procedures are performed at appropriate times, including before market placement. Testing is conducted throughout the development process, prior to deployment, and continues after deployment to ensure ongoing compliance and performance (paragraph 0). Each update undergoes rigorous validation and testing before deployment to ensure that it improves the system's performance and does not introduce new risks or biases (paragraph 1). The system's performance is evaluated against defined metrics and probabilistic thresholds that are relevant to its intended purpose (paragraph 5). Prior to training the AI models, a pre-processing phase is employed to ensure data quality, fairness, and non-discrimination (paragraph 10). After the deployment of the AI system, it is crucial to continuously monitor and evaluate its performance to ensure that it maintains its intended functionality, accuracy, and reliability (paragraph 12).",Y,N
Are technical measures for human oversight outlined?,Yes,Y,Yes,Y,Y,Y,"Yes, technical measures for human oversight are outlined. The AI system for medical expenditure prediction incorporates several layers of human oversight to fulfill the requirements of transparency, fairness, and adherence to regulatory and ethical guidelines (Paragraph 1). These measures include version control through GitHub, audit trails for model predictions, compliance audits by independent third-party organizations, continuous monitoring of performance and fairness metrics, feedback loops from medical professionals and end-users, update protocols based on monitoring results and feedback, explainability features for understanding the reasoning behind each prediction, manual overrides for human operators, fairness assessment using metrics like disparate impact and average odds difference, and regular reviews of data protection compliance with GDPR and HIPAA (Paragraph 1).",Y,Y
Are suitable risk management measures adopted?,Yes,Y,Yes,Y,Y,Y,"Yes, suitable risk management measures are adopted. The risk management process begins with the identification and analysis of known and foreseeable risks associated with the operation of the AI system (paragraph 7). Appropriate risk management measures are adopted upon the identification and evaluation of these risks (paragraph 1). These measures include regular bias audits, data quality checks, and performance evaluations of the AI system (paragraph 0). The system design is continuously reviewed and updated to eliminate or minimize risks (paragraph 1). The high-risk AI system undergoes rigorous testing to determine the most appropriate risk management measures (paragraph 3, 5). In the development and deployment of the AI system, several harmonized standards are integrated to meet the legal and technical requirements of various jurisdictions (paragraph 6). A post-market monitoring system is implemented to gather and analyze data, allowing for the identification of emerging risks, monitoring of model performance, and detection of any unexpected system behavior (paragraph 17).",Y,Y
Are specifications on input data provided?,Yes,"Y, but only very broad ones",Yes,Y,"Y, partially","Y, but only very broad ones","Yes, specifications on input data are provided. The AI system uses a dataset containing anonymized patient information relevant to medical expenditures, which complies with data privacy regulations, including GDPR (paragraph 5). The data undergoes thorough cleansing, normalization, and processing to maintain its quality and relevance (paragraph 5). The system also utilizes a diverse range of medical expenditure data to model various patient scenarios and test the system's responses (paragraph 2). Additionally, the AI system incorporates external datasets and information, such as macroeconomic indicators, to enhance the accuracy of its predictions, subject to availability, relevance, and strict compliance with data privacy laws and regulations (paragraph 3). However, the system is designed to avoid using sensitive personal attributes, such as race or gender, in its prediction process (paragraph 4, 6). Prior to training the AI models, a pre-processing phase is employed to ensure data quality, fairness, and non-discrimination (paragraph 13).",Y,N
Are risks estimated and evaluated both for intended use and conditions of reasonably foreseeable misuse?,Yes,N,Yes,N,Y,,"Yes, risks are estimated and evaluated both for intended use and conditions of reasonably foreseeable misuse. The risk management process involves identifying and analyzing known and foreseeable risks associated with the operation of the AI system, including potential misuse scenarios (paragraph 2). Risks such as inaccurate predictions, privacy concerns, and miscommunication of medical expenditure estimates are evaluated and quantified (paragraph 0 and 1). The system design is continuously reviewed and updated to eliminate or minimize risks (paragraph 6). Furthermore, residual risks associated with each identified hazard and the overall residual risk of the system are considered acceptable as long as the system is used for its intended purpose (paragraph 5).",Y,N
Are residual risks communicated to the user?,Yes,Y,Yes,Y,Y,Y,"Yes, residual risks are communicated to the user. The residual risks associated with each identified hazard and the overall residual risk of the system are communicated to users to ensure they have a clear understanding of the system's limitations and potential issues (paragraph 0 and 1).",Y,N
Are mitigation and control measures implemented for risks that cannot be eliminated?,Yes,Y,Yes,Y,Y,Y,"Yes, mitigation and control measures are implemented for risks that cannot be completely eliminated. These measures include regular bias audits, data quality checks, and performance evaluations of the AI system. Stakeholders are provided with comprehensive information about the system's operation and associated risks to ensure transparency throughout the process (paragraph 0). The system design, including the machine learning models and explanatory algorithms, is continuously reviewed and updated to eliminate or minimize risks (paragraph 4). When bias is detected, a thorough investigation is conducted to identify the root cause and implement appropriate mitigation measures, which may involve retraining the AI model, adjusting the model's parameters, or revising the data pre-processing procedures (paragraph 11).",Y,N
Are metrics and probabilistic thresholds defined preliminarily?,Yes,N,Yes,N,Y,Y,"Yes, metrics and probabilistic thresholds are defined preliminarily. The system's performance is evaluated against these defined metrics and probabilistic thresholds that are relevant to its intended purpose (paragraph 0). The AI system's performance metrics are compared against predefined thresholds and historical benchmarks to identify any anomalies or unexpected changes (paragraph 1). If the system's accuracy or reliability metrics fall below the established thresholds, an alert is triggered for further investigation (paragraph 3).",Y,N
Are measures in place to ensure individuals remain aware of the possible tendency of automatically relying or over-relying on the output produced by the high-risk AI system?,Yes,N - and I think they might misunderstand “feedback loops” as the AIA uses the term,Yes,N,Y,Y,"Yes, measures are in place to ensure individuals remain aware of the possible tendency of automatically relying or over-relying on the output produced by the high-risk AI system. The AI system is designed with built-in human oversight mechanisms to ensure the accuracy and appropriateness of the predictions (paragraph 0). Regular bias audits, data quality checks, and performance evaluations of the AI system are implemented (paragraph 1). The system incorporates several layers of human oversight, including version control, audit trails, compliance audits, continuous monitoring, feedback loops, update protocols, decision reviews, and ethical and regulatory adherence (paragraph 3). Stakeholders have the full ability to opt-out of using the system if it does not meet their specific needs (paragraph 4). The system's performance is evaluated against defined metrics and probabilistic thresholds that are relevant to its intended purpose (paragraph 5). The system incorporates built-in human oversight to ensure that the outputs are correct and is monitored during deployment, with adjustments made as necessary (paragraph 9).",Y,Y
Are known and foreseeable risks associated with the high-risk AI system identified and analyzed?,Yes,Y. Partially,Yes,Y,"Y, partially","Y, partially","Yes, known and foreseeable risks associated with the high-risk AI system are identified and analyzed. The first step in the risk management process involves identifying and analyzing these risks, which includes a comprehensive examination of the system's design, the features it utilizes, and the decision-making processes it employs. Special attention is paid to potential misuse scenarios and the risks associated with them. Factors such as data quality, potential bias in the training data, overfitting, and the possibility of misinterpreting model explanations are carefully considered during the risk identification phase (paragraph 1). Risks that arise from the intended use of the medical expenditure AI system and under conditions of reasonably foreseeable misuse are estimated and evaluated. Risks such as inaccurate predictions, privacy concerns, and miscommunication of medical expenditure estimates are evaluated and quantified (paragraph 3). Other risks include over-reliance on the system's predictions without human oversight, which may result in unnoticed errors (paragraph 4), and inherent risks of false positives and false negatives (paragraph 5). Potential unintended outcomes if the system's predictions are interpreted without considering the contextual information are also considered (paragraph 12).",Y,N
Are high-risk AI systems tested to identify the most appropriate risk management measures?,Yes,Y,Yes,Y,Y,Y,"Yes, high-risk AI systems are tested to identify the most appropriate risk management measures. The high-risk AI system undergoes rigorous testing to determine the most appropriate risk management measures. The system's performance is evaluated against defined metrics and probabilistic thresholds that are relevant to its intended purpose. Testing procedures are designed to ensure consistent performance and compliance with the requirements outlined in this section (paragraph 0). The AI system's validation involves a rigorous testing process. The system is tested under different scenarios, including stress tests and edge cases. Various situations are simulated to verify the system's response and ensure its reliability and consistency (paragraph 1). Upon identification and evaluation of risks, appropriate risk management measures are adopted. The system design, including the machine learning models and explanatory algorithms, is continuously reviewed and updated to eliminate or minimize risks (paragraph 4). The AI model is also subjected to rigorous testing to ensure its performance, reliability, and compliance with the specified requirements (paragraph 10).",Y,N
"Are foreseeable unintended outcomes and risks, including to health and safety and fundamental rights, described?",Yes,Y. Partially,Yes,Y,"Y, partially","Y, partially","Yes, foreseeable unintended outcomes and risks, including to health and safety and fundamental rights, are described. Potential unintended outcomes may occur if the system's predictions are interpreted without considering the contextual information (paragraph 0). Risks such as inaccurate predictions, privacy concerns, and miscommunication of medical expenditure estimates are evaluated and quantified (paragraph 1). The system also has limitations and potential risks, which are addressed through comprehensive data processing, bias mitigation algorithms, and robust human oversight measures (paragraph 3). Over-reliance on the system's predictions without human oversight may result in unnoticed errors (paragraph 4). False positives and false negatives are inherent risks in the AI system (paragraph 5). Potential misuse scenarios and the associated risks are also considered (paragraph 6). The risk management process identifies and analyzes known and foreseeable risks associated with the operation of the AI system, including data quality, potential bias in the training data, overfitting, and the possibility of misinterpreting model explanations (paragraph 7). The primary source of risk in the AI system stems from data bias, which can lead to unfair treatment or disparities in medical expenditure predictions (paragraph 13).",Y,N